Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cIAI
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
In light of tigecycline's activity against these resistant bacteria, tigecycline may
represent a viable new therapy for complicated intra-abdominal infections.